Familiebehandling Munkesøgaard ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.1% 3.6% 4.6% 3.5% 3.0%  
Credit score (0-100)  58 52 44 53 56  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  6,070 4,655 5,058 5,291 8,488  
EBITDA  1,156 386 188 512 656  
EBIT  1,031 322 146 473 542  
Pre-tax profit (PTP)  1,029.0 332.0 139.0 465.7 543.7  
Net earnings  803.0 259.0 108.0 363.7 424.5  
Pre-tax profit without non-rec. items  1,029 332 139 466 544  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  81.0 114 84.0 55.0 30.7  
Shareholders equity total  608 368 345 609 770  
Interest-bearing liabilities  1.0 21.0 0.0 11.0 0.0  
Balance sheet total (assets)  1,922 2,022 1,047 1,037 2,667  

Net Debt  -1,783 -1,382 -808 -878 -2,388  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  6,070 4,655 5,058 5,291 8,488  
Gross profit growth  139.4% -23.3% 8.7% 4.6% 60.4%  
Employees  10 9 11 11 15  
Employee growth %  25.0% -10.0% 22.2% 0.0% 36.4%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,922 2,022 1,047 1,037 2,667  
Balance sheet change%  338.8% 5.2% -48.2% -0.9% 157.2%  
Added value  1,156.0 386.0 188.0 515.1 656.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -76 -31 -72 -68 -138  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  17.0% 6.9% 2.9% 8.9% 6.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  80.7% 17.5% 9.8% 45.8% 29.4%  
ROI %  227.8% 46.2% 23.0% 79.3% 78.4%  
ROE %  153.5% 53.1% 30.3% 76.3% 61.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  45.6% 23.9% 33.2% 58.7% 45.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -154.2% -358.0% -429.8% -171.5% -363.9%  
Gearing %  0.2% 5.7% 0.0% 1.8% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  11.8% 127.3% 104.8% 204.4% 19.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  3.3 2.3 2.1 2.3 2.7  
Current Ratio  1.6 1.4 2.1 2.3 1.3  
Cash and cash equivalent  1,784.0 1,403.0 808.0 888.7 2,388.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  690.0 590.0 498.0 554.8 529.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  116 43 17 47 44  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  116 43 17 47 44  
EBIT / employee  103 36 13 43 36  
Net earnings / employee  80 29 10 33 28